Skip to main content
Tech.euFundingExplorerBeta

Micreos

Micreos, a Wageningen, The Netherlands-based developer of phage technology for targeted control of bacteria.

Micreos has raised €87M across 3 funding rounds, most recently a round in Oct 2022. Based in Wageningen, Netherlands; founded 2006; active in Healthtech. Data as of 28 Oct 2026.

Wageningen, NetherlandsFounded 2006www.micreos.com ↗
Total raised
€87M
€87,000,000
Funding rounds
3
Investors
0
distinct backers
Active since
2019-04
latest 2022-10

Funding by year

EUR raised per year
Micreos — funding by year — interactive chart.
Data table
Micreos — funding by year
2019€30M
2021€32M
2022€25M

Signals

Medium confidence
Raise-next likelihood5
base rate 30% for Other
  • ▼ Past typical raise window
  • ▼ Down/flat last round
Exit likelihood7
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▼ Old (20y) — past typical exit age
  • ▼ No recent equity round (debt-only or quiet)

Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2022-10-25Other€25M—View deal →
2021-10-01Other€32M—View deal →
2019-04-01Other€30M—View deal →

Similar companies

same sector or country

Global coverage: FundingData